VIM and odontogenic neoplasm: In consideration of the results of the current study, we argue the practical usefulness of EMA and vimentin in this setting, due to consistent immunoreactivity for such markers in many distinct salivary gland tumors and, to a lesser extent, in odontogenic tumors as well.